Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

OTHER 35NIH 12NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 43Other hematologic neoplasm 27CNS 25Sarcoma 20Thoracic 17Genitourinary 13Gynecologic 6Plasma cell 3Dermatologic 3Other solid neoplasm 2Endocrine 2Classical hematology 2Myeloid 1Gastrointestinal 1

Conditions

Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Leukemia, Myeloid, Acute 1Down Syndrome 1

Interventions

Cytarabine 9Busulfan 7Cyclophosphamide 6Whole-Body Irradiation 5Peripheral Blood Stem Cell Transplantation 5Mycophenolic Acid 5Methotrexate 5fludarabine 4nilotinib 3merphos 3fludarabine phosphate 3Tacrolimus 3Radiotherapy 3Polymerase Chain Reaction 3Mitoxantrone 3Melphalan 3Idarubicin 3Daunorubicin 3Cytogenetic Analysis 3Cyclosporine 3Asparaginase 3bosutinib 2Thioguanine 2Stem Cell Transplantation 2Patient Reported Outcome Measures 2Mesna 2Imatinib Mesylate 2Granulocyte Colony-Stimulating Factor 2Gemtuzumab 2Flow Cytometry 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Etoposide × Myeloid × Clear all
NCT02521493 2025-08-01

Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome

Children's Oncology Group

Phase 3 Active not recruiting
280 enrolled 13 charts
MyeloidOther hematologic neoplasm

Down Syndrome, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡